We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.
featured
Published in Eye Care

Journal Scan / Research · January 14, 2020

Incidence of Glaucoma or Ocular Hypertension After Repeated Anti-Vascular Endothelial Growth Factor Injections for Macular Degeneration

Clinical Ophthalmology (Auckland, N.Z.)

 

Additional Info

Disclosure statements are available on the authors' profiles:

Clinical Ophthalmology (Auckland, N.Z.)
Incidence of Glaucoma or Ocular Hypertension After Repeated Anti-Vascular Endothelial Growth Factor Injections for Macular Degeneration
Clin Ophthalmol 2019 Dec 24;2019(13)2563-2572, JB Wingard, DAP Delzell, NV Houlihan, J Lin, JP Gieser

Further Reading